NO994631L - Fremgangsmåter og preparater for behandling av eggstokkreft - Google Patents

Fremgangsmåter og preparater for behandling av eggstokkreft

Info

Publication number
NO994631L
NO994631L NO994631A NO994631A NO994631L NO 994631 L NO994631 L NO 994631L NO 994631 A NO994631 A NO 994631A NO 994631 A NO994631 A NO 994631A NO 994631 L NO994631 L NO 994631L
Authority
NO
Norway
Prior art keywords
preparations
ovarian cancer
methods
treatment
taxanes
Prior art date
Application number
NO994631A
Other languages
English (en)
Norwegian (no)
Other versions
NO994631D0 (no
Inventor
Karl L Mettinger
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of NO994631D0 publication Critical patent/NO994631D0/no
Publication of NO994631L publication Critical patent/NO994631L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO994631A 1997-03-27 1999-09-23 Fremgangsmåter og preparater for behandling av eggstokkreft NO994631L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4162897P 1997-03-27 1997-03-27
PCT/US1998/006232 WO1998042330A1 (en) 1997-03-27 1998-03-27 Methods and compositions for treatment of ovarian cancer

Publications (2)

Publication Number Publication Date
NO994631D0 NO994631D0 (no) 1999-09-23
NO994631L true NO994631L (no) 1999-11-23

Family

ID=21917518

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994631A NO994631L (no) 1997-03-27 1999-09-23 Fremgangsmåter og preparater for behandling av eggstokkreft

Country Status (11)

Country Link
US (1) US6334445B1 (de)
EP (1) EP1007029A4 (de)
JP (1) JP2001524963A (de)
KR (1) KR20010005740A (de)
CN (1) CN1254279A (de)
AU (1) AU744095B2 (de)
CA (1) CA2285391A1 (de)
IL (1) IL132094A0 (de)
NO (1) NO994631L (de)
PL (1) PL335891A1 (de)
WO (1) WO1998042330A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL138767A0 (en) * 1998-04-01 2001-10-31 Rtp Pharma Inc Anticancer compositions
EP1096957A1 (de) 1998-06-18 2001-05-09 Johns Hopkins University School of Medicine Verfahren und reagentien zur intramuskulären zufuhr von nukleinsäuren
US6350464B1 (en) 1999-01-11 2002-02-26 Guilford Pharmaceuticals, Inc. Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
US6537585B1 (en) 1999-03-26 2003-03-25 Guilford Pharmaceuticals, Inc. Methods and compositions for treating solid tumors
DE10244847A1 (de) * 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
JP2006514698A (ja) * 2002-10-30 2006-05-11 スフェリックス， インコーポレイテッド ナノ粒子生物活性物質
WO2007035842A2 (en) * 2005-09-21 2007-03-29 Ccc Diagnostics, Llc Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac)
US8927019B2 (en) * 2007-06-01 2015-01-06 Abraxis Bioscience, Llc Methods and compositions for treating recurrent cancer
EP2566474B1 (de) 2010-05-03 2017-11-15 Teikoku Pharma USA, Inc. Nichtwässrige taxan-pro-emulsionsformulierungen sowie verfahren zu ihrer herstellung und verwendung
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN103432141A (zh) * 2013-08-29 2013-12-11 南京大学 Chukrasone A在治疗卵巢癌药物中的应用
US10726097B2 (en) * 2015-10-16 2020-07-28 Carefusion 303, Inc. Readmission risk scores

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620875A (en) * 1995-02-17 1997-04-15 University Of Portland Transfer of taxol from yew tree cuttings into a culture medium over time

Also Published As

Publication number Publication date
AU744095B2 (en) 2002-02-14
CN1254279A (zh) 2000-05-24
IL132094A0 (en) 2001-03-19
US6334445B1 (en) 2002-01-01
CA2285391A1 (en) 1998-10-01
JP2001524963A (ja) 2001-12-04
AU6787498A (en) 1998-10-20
WO1998042330A1 (en) 1998-10-01
NO994631D0 (no) 1999-09-23
PL335891A1 (en) 2000-05-22
EP1007029A1 (de) 2000-06-14
EP1007029A4 (de) 2003-03-26
KR20010005740A (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
NO994631L (no) Fremgangsmåter og preparater for behandling av eggstokkreft
EA200000747A1 (ru) СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
NO20013727D0 (no) Anvendelse av Botulinumtoksin B for fremstilling av et medikament
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
PT946151E (pt) Forma de dosagem de dose crescente
AU2003239393A1 (en) Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DK541189D0 (da) Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af interstitiel cystitis
DE69821498D1 (de) Verwendung von amifostin
PT1150703E (pt) Terapia de esclerose multipla com chaperonina 10 e beta-interferao
HUP0302293A2 (hu) Rák kezelése aplidin és egy izomvédő szer együttes alkalmazásával
PT1007085E (pt) Utilizacao da hormona de crescimento em composicoes para o tratamento da resistencia a insulina no coracao
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
UA31853A (uk) Спосіб лікування хронічного бронхіту
NO994712L (no) FremgangsmÕte og sammensetninger for behandling av AIDS- tilknyttet Kaposi-sarkom
UA30956A (uk) Спосіб лікування алергічного риніту
UA40974A (uk) Спосіб лікування міопії у дітей та підлітків
DE69431731D1 (de) Orale oder intramuskuläre Behandlung von Pankreaskrebs durch wasserunlösliches S-Camptothecin mit geschlossenem Lactonring
UA36093A (uk) Спосіб лікування хронічного бронхіту
UA38048A (uk) Спосіб лікування гіпертонічної хвороби
UA37666A (uk) Спосіб комлексної терапії простої шизофренії з суїцидальною поведінкою
UA30659A (uk) Спосіб купіровання опіатної залежності
UA28966A (uk) Спосіб лікування ішемічної хвороби серця